The company have significantly advanced the development of a innovative treatment for ATTR-CM, utilizing the investigational drug. Early patient results indicates potential outcomes for patients diagnosed by a serious https://attruby738341.newsbloger.com/42746817/bridgebio-advances-amyloidosis-therapy-through-the-drug